A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday. Reuters Health Information
A large, randomized controlled trial finds transcranial magnetic stimulation is safe and effective for treatment-resistant major depression. Medscape Medical News
Ophthalmologic abnormalities are common in patients with dementia and untreated poor vision may intensify cognitive decline, a new study suggests. Medscape Medical News
A 35-year-old woman is seeing a psychiatrist for treatment of her major depression. After four weeks on fluoxetine, her psychiatrist decides to try augmentation. What drug should be prescribed? USMLEasy from McGraw-Hill